An observational study in Peripheral Neuropathy, sponsored by Superior University. Active, not recruiting at 1 site in Pakistan. Open to female participants aged 21 Years to 51 Years. Per ClinicalTrials.gov, last updated 2025-07-09.
Sponsored by Superior University · Observational
This research aims to find the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.
1,003 studies on the registry are indexed under Peripheral Nervous System Diseases; 177 are open to participants now.
This study's enrollment of 45 is below the median of 90 across 188 observational studies indexed under Peripheral Nervous System Diseases.
Browse Peripheral Nervous System Diseases studies →Superior University is the lead sponsor of 242 studies on the registry; 24 are open to participants now.
Counted across the registry records on this site, refreshed daily.
to find out the Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer
Exclusion Criteria:
to find out the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.
Douleur Neuropathique 4 (DN4) Questionnaire
The DN4 questionnaire is used to assess the neuropathic pain, if the score is \> 4 it indicates the neuropathic pain is present while \<3 than is unlikely.
Time frame: 6 Month
visual analog scale
The visual analog scale provide quantitative measurement of pain level which is from no pain to severe pain . The range of the scale is in between 0-10mm. 0-4 is consider as no pain, 5-44 is consider as mild pain,45-74 is moderate and \> 75 is consider as severe pain.
Time frame: 6 Months
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peripheral Nervous System Diseases→
Superior University